Caduet detailed information: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Caduet detailed information": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
'''Caduet''' is a medication approved by the [[Food and Drug Administration|US FDA]] for the treatment of [[hypercholesterolemia|high cholesterol]] and [[hypertension|high blood pressure]]. It is a [[fixed dose combination]] drug containing [[atorvastatin]] (Lipitor) and [[amlodipine]] (Norvasc). It is currently being marketed by the [[pharmaceutical company]] [[Pfizer]]. | '''Caduet''' is a medication approved by the [[Food and Drug Administration|US FDA]] for the treatment of [[hypercholesterolemia|high cholesterol]] and [[hypertension|high blood pressure]]. It is a [[fixed dose combination]] drug containing [[atorvastatin]] (Lipitor) and [[amlodipine]] (Norvasc). It is currently being marketed by the [[pharmaceutical company]] [[Pfizer]]. | ||
Latest revision as of 23:21, 8 August 2012
Caduet is a medication approved by the US FDA for the treatment of high cholesterol and high blood pressure. It is a fixed dose combination drug containing atorvastatin (Lipitor) and amlodipine (Norvasc). It is currently being marketed by the pharmaceutical company Pfizer.
External links
- Manufacturer's site (caduet.com)